Structural Genomics Consortium: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Wayne Decatur (talk | contribs)
mNo edit summary
Wayne Decatur (talk | contribs)
mNo edit summary
Line 1: Line 1:
[http://www.thesgc.org/ The Structural Genomics Consortium (SGC)] according to their site "is a public-private partnership to promote the development of new
[http://www.thesgc.org/ The Structural Genomics Consortium (SGC)] according to their site "is a public-private partnership to promote the development of new
medicines by carrying out basic science of relevance to drug discovery.  The core mandate of the SGC is to determine 3D structures of proteins of biomedical importance and proteins that represent potential drug targets". They have an [http://www.thesgc.org/about/open_access.php open-access policy].
medicines by carrying out basic science of relevance to drug discovery.  The core mandate of the SGC is to determine 3D structures of proteins of biomedical importance and proteins that represent potential drug targets". They have an [http://www.thesgc.org/about/open_access.php open-access policy].<br>
As of September 2010, the international team of 180 scientists solved its 1,000th structure.  





Revision as of 16:42, 14 October 2010

The Structural Genomics Consortium (SGC) according to their site "is a public-private partnership to promote the development of new medicines by carrying out basic science of relevance to drug discovery. The core mandate of the SGC is to determine 3D structures of proteins of biomedical importance and proteins that represent potential drug targets". They have an open-access policy.
As of September 2010, the international team of 180 scientists solved its 1,000th structure.


To view automatically seeded indices concerning the Structural Genomics Consortium (SGC), see:



Additional Literature and Resources

See also

Proteopedia Page Contributors and Editors (what is this?)

Wayne Decatur, Eric Martz